ASO Author Reflections: Management of Patients with Soft Tissue Sarcoma Following Unplanned Excision Raymond S. TraweekChristina L. RolandChristopher P. Scally ASO Author Reflections 08 September 2022 Pages: 490 - 491
ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease Raymond S. TraweekAllison N. MartinChristopher P. Scally ASO Visual Abstract 16 October 2022 Pages: 492 - 492
Prognosis of Patients with Cutaneous Angiosarcoma After Surgical Resection with Curative Intent: Is There a Difference Between the Subtypes? Sophie J. M. ReijersEva A. Huis in ’t VeldWinan J. van Houdt Sarcoma 08 October 2022 Pages: 493 - 502
ASO Author Reflections: Multimodality Treatment of Cutaneous Angiosarcoma Sophie J. M. ReijersWinan J. van Houdt ASO Author Reflections 16 October 2022 Pages: 503 - 503
ASO Visual Abstract: Prognosis of Patients with Cutaneous Angiosarcoma After Surgical Resection with Curative Intent—Is There a Difference Between the Subtypes? Sophie J. M. ReijersEva A. Huis in’t VeldWinan J. van Houdt ASO Visual Abstract 04 November 2022 Pages: 504 - 505
Comparison of the Perioperative Outcomes for Thoracoscopic Thymectomy Between the Subxiphoid Approach and the Lateral Intercostal Approach for Masaoka-Koga I-II Thymoma: A Propensity Score-Matching Analysis Xinyu YangShuai WangJianyong Ding Thoracic Oncology 15 July 2022 Pages: 506 - 514
ASO Visual Abstract: Comparison of Perioperative Outcomes of Subxiphoid Approach versus Lateral Intercostal Approach Thoracoscopic Thymectomy for Masaoka–Koga I–II Thymoma—a Propensity Score Matching Analysis Xinyu YangShuai WangJianyong Ding ASO Visual Abstract 05 November 2022 Pages: 515 - 516
Understanding Racial Differences in Lung Cancer Surgery Through a Statewide Quality Collaborative Sidra N. BonnerChang HeKiran Lagisetty Thoracic Oncology 26 August 2022 Pages: 517 - 526
ASO Visual Abstract: Understanding Racial Differences in Lung Cancer Surgery Through a Statewide Quality Collaborative Sidra N. BonnerChang HeKiran Lagisetty ASO Visual Abstract 16 October 2022 Pages: 527 - 528
Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy and Surgery Zhaohui LiangKongjia LuoBaoqing Chen Thoracic Oncology 20 September 2022 Pages: 529 - 538
ASO Author Reflections: The Prophets of Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Trimodality Therapy Zhaohui LiangMihnea P. DragomirBaoqing Chen ASO Author Reflections 02 October 2022 Pages: 539 - 540
ASO Visual Abstract: Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy and Surgery Zhaohui LiangKongjia LuoBaoqing Chen ASO Visual Abstract 13 November 2022 Pages: 541 - 542
Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural Disseminated Thymoma: A Systematic Literature Review Tom VandaeleJan Van SlambrouckLaurens J. Ceulemans Thoracic Oncology 23 September 2022 Pages: 543 - 560
ASO Visual Abstract: Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural Disseminated Thymoma—A Systematic Literature Review Tom VandaeleJan Van SlambrouckLaurens J. Ceulemans ASO Visual Abstract 16 September 2022 Pages: 561 - 562
Contrast-Enhanced Radiologic Evaluation of Gastric Conduit Emptying After Esophagectomy Minke L. FeenstraLily AlkemadeWietse J. Eshuis Thoracic Oncology Open access 10 October 2022 Pages: 563 - 570
ASO Visual Abstract: Contrast-Enhanced Radiologic Evaluation of Gastric Conduit Emptying after Esophagectomy Minke L. FeenstraLily AlkemadeWietse J. Eshuis ASO Visual Abstract 10 October 2022 Pages: 571 - 572
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease? Stephanie A. BlankensteinJohannes J. BonenkampAlexander C. J. van Akkooi Melanoma 06 October 2022 Pages: 573 - 586
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease? Stephanie A. BlankensteinJohannes J. BonenkampAlexander C. J. van Akkooi ASO Visual Abstract 01 November 2022 Pages: 587 - 588
Adoptive Cellular Therapy for Metastatic Melanoma: The Road to Commercialization and Treatment Guidelines for Clinicians Keshav KooragayalaJohanna LouYoung K. Hong Melanoma 16 September 2022 Pages: 589 - 601
ASO Author Reflections: Commercialization of Adaptive Cell Therapy for Metastatic Melanoma Keshav KooragayalaJohanna LouYoung Ki Hong ASO Author Reflections 26 September 2022 Pages: 602 - 603
Sustained Systemic Inflammatory Response Predicts Survival in Patients with Hepatocellular Carcinoma After Hepatic Resection Koichiro HarukiTomohiko TaniaiToru Ikegami Translational Research 04 September 2022 Pages: 604 - 613
ASO Author Reflections: Evaluation of the Longitudinal Changes in the Systemic Inflammatory Response of Patients With Hepatocellular Carcinoma Koichiro HarukiTomohiko TaniaiToru Ikegami ASO Author Reflections 23 August 2022 Pages: 614 - 615
ASO Visual Abstract: Sustained Systemic Inflammatory Response Predicts Survival in Patients with Hepatocellular Carcinoma After Hepatic Resection Koichiro HarukiTomohiko TaniaiToru Ikegami ASO Visual Abstract 14 September 2022 Pages: 616 - 617
Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model Hiroto NishinoMichael A. TurnerMichael Bouvet Translational Research Open access 04 September 2022 Pages: 618 - 625
ASO Visual Abstract: Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model Hiroto NishinoMichael A. TurnerMichael Bouvet ASO Visual Abstract 02 September 2022 Pages: 626 - 627
Gamma-aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic Target in Gastric Cancer Koichi SawakiMitsuro KandaYasuhiro Kodera Translational Research 20 September 2022 Pages: 628 - 636
ASO Author Reflections: Gamma-Aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic Target in Gastric Cancer Koichi SawakiMitsuro KandaYasuhiro Kodera ASO Author Reflections 20 September 2022 Pages: 637 - 638
ASO Visual Abstract: Gamma-Aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic Target in Gastric Cancer Koichi SawakiMitsuro KandaYasuhiro Kodera ASO Visual Abstract 07 October 2022 Pages: 639 - 640
A c-MET-Targeted Topical Fluorescent Probe cMBP-ICG Improves Oral Squamous Cell Carcinoma Detection in Humans Jingbo WangSiyi LiXiaofeng Tao Translational Research Open access 02 October 2022 Pages: 641 - 651
ASO Author Reflections: Topically Applied Targeted Near-Infrared Fluorescence Imaging Probe Helps Detect Head and Neck Squamous Cell Carcinoma Wang JingboYing YuanXiaofeng Tao ASO Author Reflections 30 September 2022 Pages: 652 - 652